Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
U.S. regulators have begun a CIP-based compliance clock for stablecoin issuers, tying direct customer onboarding to f...
Offerpad rolls out two internal AI platforms, SCOUT and HENRY, as the company pursues 1,000 quarterly home transactio...
A single optimistic forecast argues spacex stock before soars could push the company past a $10 trillion market capit...
Regulators deliver a landmark clarification for crypto assets, signaling non-securities for most tokens. But the fram...
SpaceX has joined the NASDAQ 100, but veteran skepticism remains. Famed investor jeremy gratham says today’s hype cou...
BNB Chain invites builders, investors, and institutional leaders to a day of demos and expert panels at PAMM during C...
Strategy increases its USD cash pile by $450 million via a stock offering, bringing total USD reserves to $3 billion ...
Nasdaq welcomes the 21Shares Canton Network ETF, the latest milestone in the ongoing crypto ETF surge. The fund aims ...
As the Senate Banking Committee prepares a pivotal vote, crypto stakeholders weigh the potential for regulatory clari...
President Trump has nominated Kevin Warsh to chair the Federal Reserve, a move that could reshape U.S. monetary polic...
Grayscale Investments and VanEck filed amendments to their spot BNB ETF registrations with the SEC on May 15, 2026, s...